Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunological Memory01:23

Immunological Memory

13.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
13.8K
Vaccinations01:51

Vaccinations

48.6K
Overview
48.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

78.8K
Overview
78.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

801
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
801
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

7.3K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
7.3K
Cancer Vaccines01:30

Cancer Vaccines

600
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
600

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A metabolic boost to mRNA vaccines.

Nature materials·2026
Same author

Photocontrolled immunotherapy: a BODIPY-caged MSA-2 for spatiotemporal activation of STING with visible light.

New journal of chemistry = Nouveau journal de chimie·2026
Same author

A molecularly defined polymeric platform for environmentally responsive activation of STING to enhance cancer immunotherapy.

Biomaterials·2026
Same author

Stenotrophomonas maltophilia Bloodstream Infection Outbreak in Acute Care Hospital, California, USA, 2022-2023<sup>1</sup>.

Emerging infectious diseases·2026
Same author

Glutamine synthetase deficiency enhances CD8 T cell survival and stress resilience in the tumor microenvironment.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Macromolecular Diamidobenzimidazole Conjugates Can Activate Stimulator of Interferon Genes.

Journal of the American Chemical Society·2025
Same journal

COBRA Hemagglutinin and cGAMP Loaded Ace-DEX Microparticles Provide a Broadly Active and Shelf-Stable Influenza Vaccine Platform.

Advanced therapeutics·2026
Same journal

Implanted Miniature Light Devices for Phototherapeutics.

Advanced therapeutics·2026
Same journal

Cold Plasma Generates a Localized Inflammatory Response and Promotes Muscle Repair.

Advanced therapeutics·2026
Same journal

ROS-activatable Prodrug of Doxazolidine as Novel Cancer Therapy Paradigm.

Advanced therapeutics·2026
Same journal

Enzyme-Based Synthetic Protein Nanoparticles as Colloidal Antioxidants.

Advanced therapeutics·2025
Same journal

Inhalational Delivery of <i>β-</i>glucan-chitosan-poly(lactic co-glycolic) acid Nanoparticles Enhance Alveolar Macrophage Rifampin Concentrations for the Treatment of Tuberculosis.

Advanced therapeutics·2025
See all related articles

Related Experiment Video

Updated: Nov 5, 2025

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

8.8K

Engineering Vaccines for Tissue-Resident Memory T Cells.

Frances C Knight1, John T Wilson1,2,3,4,5

  • 1Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.

Advanced Therapeutics
|May 17, 2021
PubMed
Summary
This summary is machine-generated.

Next-generation vaccines aim to generate tissue-resident memory T cells (TRM) for enhanced immunity against infections and cancer. Immunoengineering offers innovative solutions for developing these crucial TRM vaccines.

Keywords:
biomaterialsimmunoengineeringmucosal immunitynanoparticletissue-resident memory T cellsvaccine

More Related Videos

Application of Long-term cultured Interferon-&#947; Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.4K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

Related Experiment Videos

Last Updated: Nov 5, 2025

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

8.8K
Application of Long-term cultured Interferon-&#947; Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.4K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.7K

Area of Science:

  • Immunology
  • Vaccinology
  • Biomedical Engineering

Background:

  • Tissue-resident memory T cells (TRM) reside in tissues, offering rapid local immune responses.
  • TRM are crucial for immunity against infectious diseases like influenza and tuberculosis, and in cancer.
  • Generating TRM is a key goal for next-generation vaccine development.

Purpose of the Study:

  • To review recent advancements in vaccine technologies for generating TRM.
  • To explore the role of immunoengineering in developing TRM vaccines.
  • To provide insights into the future of TRM vaccine engineering.

Main Methods:

  • Review of current literature on TRM vaccine technologies.
  • Analysis of viral vectors, virus-like particles, and biomaterials for TRM induction.
  • Discussion of immunoengineering principles applied to vaccine design.

Main Results:

  • Various vaccine platforms show promise for generating TRM.
  • Immunoengineering approaches are advancing TRM vaccine design.
  • TRM vaccines are essential for combating infectious diseases and cancer.

Conclusions:

  • Engineering vaccines to induce TRM is critical for future public health.
  • Continued innovation in vaccine technology and immunoengineering will drive progress.
  • TRM-focused vaccines hold significant potential for infection and cancer protection.